Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients

Journal of the American Society of Nephrology

Volumn 9, Issue 8, 1998, Pages 1511-1520

  Weber, Lutz T ^b   Shipkova, Maria ^b   Lamersdorf, Timo ^b   Niedmann, Paul D ^b   Wiesel, Manfred ^b   Mandelbaum, Alexander ^b   Zimmerhackl, Lothar B ^b   Schütz, Ekkehard ^b   Mehls, Otto ^b   Oellerich, Michael ^b   Armstrong, Victor W ^b   Tönshoff, Burkhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031926842     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Eugui EM, Allison AC: Immunosuppressive activity of mycophenolate mofetil. Ann NY Acad Sci 685: 309-329, 1993
2. Matthews TR: Discovery and rationale for the development of mycophenolate mofetil. In: Principles of Drug Development in Transplantation and Autoimmunity, edited by Lieberman R, Mukherjee A, Austin, TX, Landes Bioscience, 1994, pp 437-449
3. Allison AC, Eugui EM: Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10: 77-84, 1996
4. Sollinger HW, for the U.S. Renal Transplant Mycophenolate Mofetil Study Group: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60: 225-232, 1995
5. Tricontinental Mycophenolate Mofetil Renal Transplant Study Group: A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61: 1029-1037, 1996
6. European Mycophenolate Mofetil Cooperative Study Group: Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancer 345: 1321-1325, 1995
7. Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B: Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation. Transplant Proc 29: 340-341, 1997
8. Staskewitz A, Kirste G, Brandis M, Tönshoff B, Helmchen U, Zimmerhackl LB: Nierentransplantation im Kindesalter: Erste Erfahrungen mit Mycophenolat Mofetil (MMF). Tx Med 10: 34-37, 1998
9. Bullingham RES, Nicholls A, Hale M: Pharmacokinetics of mycophenolate mofetil (RS 61443): A short review. Transplant Proc 28: 925-929, 1996
10. Bullingham RES, Monroe S, Nicholls A, Hale M: Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol 36: 315-324, 1996
11. Nowak J, Shaw LM: Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics. Clin Chem 41: 1011-1017, 1995
12. Ettenger RB, Warshaw B, Mentser M, Potter D, Moulton L, Marik J, Cohen A, Nast C, Gales B, Nichols A, Hale M, Linna J: Mycophenolate mofetil (MMF) in pediatric renal transplantation [Abstract]. Pediatr Nephrol 10: C39, 1996
13. DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17: 863-871, 1916
14. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34: 571-590, 1987
15. Zar JH: Biostatistical Analysis, Englewood Cliffs, NJ, Prentice Hall, 1984
16. Fulton B, Markham A: Mycophenolate mofetil: A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 51: 278-298, 1996
17. Wu JC: Mycophenolate mofetil: Molecular mechanisms of action. Perspect Drug Discov Des 2: 185-204, 1994
18. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C, for the International Mycophenolate Mofetil Renal Transplant Study Group: Mycophenolate mofetil in renal allograft recipients. Transplantation 63: 39-47, 1997
19. Ravelli AM, Ledermann SE, Bisset WM, Trompeter RS, Barratt TM, Milla PJ: Foregut motor function in chronic renal failure. Arch Dis Child 67: 1343-1347, 1992
20. MacKichan JJ: Influence of protein binding and use of unbound (free) drug concentration. In: Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, edited by Evans WE, Schentag JJ, Jusko WJ, Relling MV, Vancouver, Applied Therapeutics, 1992, pp 5-1-5-48